Recommendations for the use of mechanical circulatory support: Device strategies and patient selection: A scientific statement from the American heart association

Circulation

Volumn 126, Issue 22, 2012, Pages 2648-2667

  Peura, Jennifer L ^a   Colvin Adams, Monica ^a   Francis, Gary S ^a   Grady, Kathleen L ^a   Hoffman, Timothy M ^a   Jessup, Mariell ^a   John, Ranjit ^a   Kiernan, Michael S ^a   Mitchell, Judith E ^a   O'Connell, John B ^a   Pagani, Francis D ^a   Petty, Michael ^a   Ravichandran, Pasala ^a   Rogers, Joseph G ^a   Semigran, Marc J ^a   Toole, J Matthew ^a  

^a AMERICAN HEART ASSOCIATION   (United States)

Author keywords

AHA Scientific Statements; cardiomyopathy; cardiovascular surgery; congestive (heart failure); heart failure; mechanical circulatory support; pulmonary circulation and disease; transplantation; ventricular assistance

Indexed keywords

ABLATION THERAPY; ANGIOPLASTY; AORTA PRESSURE; AORTA VALVE DISEASE; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL HEART; ASSISTED CIRCULATION; BLEEDING; BLOOD CLOTTING DISORDER; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CLINICAL TRIAL (TOPIC); CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; COUNTERPULSATION; DECISION MAKING; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; HEARING IMPAIRMENT; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART INFARCTION; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEART VENTRICLE EJECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE TACHYCARDIA; HEMODYNAMIC PARAMETERS; HEMOFILTRATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTRAAORTIC BALLOON PUMP; ISCHEMIC CARDIOMYOPATHY; KIDNEY DYSFUNCTION; LEG ISCHEMIA; LIMB ISCHEMIA; LIVER DYSFUNCTION; LONG TERM SURVIVAL; MALNUTRITION; MEDICAL SOCIETY; MEMBRANE OXYGENATOR; MENTAL DISEASE; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; MYOCARDITIS; OBESITY; OUTCOME ASSESSMENT; OUTPATIENT; PACEMAKER; PATIENT CARE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SHUNTING; SURVIVAL RATE; THROMBOSIS; TRICUSPID VALVE REGURGITATION; VENTRICULAR ASSIST DEVICE; VISUAL IMPAIRMENT;

AMERICAN HEART ASSOCIATION; CARDIOLOGY; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART FAILURE; HEART, ARTIFICIAL; HUMANS; INTRA-AORTIC BALLOON PUMPING; PATIENT SELECTION; UNITED STATES;

EID: 84870250389     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3182769a54     Document Type: Article

References (143)

1. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954;37:171-185; passim.
2. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;119: 1977-2016.
3. Metra M, Ponikowski P, Dickstein K, McMurray JJ, Gavazzi A, Bergh CH, Fraser AG, Jaarsma T, Pitsis A, Mohacsi P, Bohm M, Anker S, Dargie H, Brutsaert D, Komajda M; Heart Failure Association of the European Society of Cardiology. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007;9:684-694.
4. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 2005;112:e154-e235.
5. Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail. 2003;9:180-187.
6. Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ Heart Fail. 2009;2:320-324.
7. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;119:e391-e479.
8. Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1-e194.
9. Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, Heckman GA, Howlett JG, Ignaszewski A, Johnstone DE, Jong P, McKelvie RS, Moe GW, Parker JD, Rao V, Ross HJ, Sequeira EJ, Svendsen AM, Teo K, Tsuyuki RT, White M; Canadian Cardiovascular Society. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22:23-45.
10. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J. 2008;29:2388-2442.
11. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Eur Heart J. 2010;31:2677-2687.
12. Duncan BW. Pediatric mechanical circulatory support in the United States: past, present, and future. ASAIO J. 2006;52:525-529.
13. Luo XJ, Wang W, Hu SS, Sun HS, Gao HW, Long C, Song YH, Xu JP. Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients. Interact Cardiovasc Thorac Surg. 2009;9:296-300.
14. Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, Cosgrove DM 3rd. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg. 2001;122: 92-102.
15. Meliones JN, Custer JR, Snedecor S, Moler FW, O'Rourke PP, Delius RE. Extracorporeal life support for cardiac assist in pediatric patients: review of ELSO Registry data. Circulation. 1991;84(suppl):III-168-III-172.
16. BarZiv SM, McCrindle BW, West LJ, Edgell D, Coles JG, VanArsdell GS, Bohn D, Perez R, Campbell A, Dipchand AI. Outcomes of pediatric patients bridged to heart transplantation from extracorporeal membrane oxygenation support. ASAIO J. 2007;53:97-102.
17. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. 2001;122:440-448.
18. Pages ON, Aubert S, Combes A, Luyt CE, Pavie A, Leger P, Gandjbakhch I, Leprince P. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg. 2009;137: 194-197.
19. DeBakey ME. Left ventricular bypass pump for cardiac assistance: clinical experience. Am J Cardiol. 1971;27:3-11.
20. Guyton RA, Schonberger JP, Everts PA, Jett GK, Gray LA Jr, Gielchinsky I, Raess DH, Vlahakes GJ, Woolley SR, Gangahar DM, Soltanzadeh H, Piccione WJ, Vaughn CC, Boonstra PW, Buckley MJ. Postcardiotomy shock: clinical evaluation of the BVS 5000 Biventricular Support System. Ann Thorac Surg. 1993;56:346-356.
21. Wassenberg PA. The Abiomed BVS 5000 biventricular support system. Perfusion. 2000;15:369-371.
22. Samuels LE, Holmes EC, Thomas MP, Entwistle JC 3rd, Morris RJ, Narula J, Wechsler AS. Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann Thorac Surg. 2001;71(suppl):S67-S72.
23. Morgan JA, Stewart AS, Lee BJ, Oz MC, Naka Y. Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO J. 2004;50:360-363.
24. De Robertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A. Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transplant. 2006;25:181-186.
25. Mueller JP, Kuenzli A, Reuthebuch O, Dasse K, Kent S, Zuend G, Turina MI, Lachat ML. The CentriMag: a new optimized centrifugal blood pump with levitating impeller. Heart Surg Forum. 2004;7: E477-E480.
26. John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, Frazier OH, Joyce LD. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932-939.
27. Haj-Yahia S, Birks EJ, Amrani M, Petrou M, Bahrami T, Dreyfus G, Khaghani A. Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump. J Thorac Cardiovasc Surg. 2009;138: 227-230.
28. Gregoric ID, Jacob LP, La Francesca S, Bruckner BA, Cohn WE, Loyalka P, Kar B, Frazier OH. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J. 2008;35:125-129.
29. Bruckner BA, Jacob LP, Gregoric ID, Loyalka P, Kar B, Cohn WE, La Francesca S, Radovancevic B, Frazier OH. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J. 2008;35:447-450.
30. Idelchik GM, Simpson L, Civitello AB, Loyalka P, Gregoric ID, Delgado R 3rd, Kar B. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008;27:106-111.
31. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688-696.
32. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschinger J, Kastrati A, Schomig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52: 1584-1588.
33. Siegenthaler MP, Brehm K, Strecker T, Hanke T, Notzold A, Olschewski M, Weyand M, Sievers H, Beyersdorf F. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg. 2004;127:812-822.
34. Samoukovic G, Rosu C, Giannetti N, Cecere R. The Impella LP 5.0 as a bridge to long-term circulatory support. Interact Cardiovasc Thorac Surg. 2009;8:682-683.
35. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686-697.
36. Hoefer D, Ruttmann E, Poelzl G, Kilo J, Hoermann C, Margreiter R, Laufer G, Antretter H. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg. 2006;82: 28-33.
37. Haft JW, Pagani FD, Romano MA, Leventhal CL, Dyke DB, Matthews JC. Short-and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support. Ann Thorac Surg. 2009;88:711-717.
38. Thoratec ventricular assist device instructions for use. Thoratec Corp. Document 15003I. 2004.
39. Kirsch M, Vermes E, Damy T, Nakashima K, Senechal M, Boval B, Drouet L, Loisance D. Single-centre experience with the Thoratec Paracorporeal Ventricular Assist Device for patients with primary cardiac failure. Arch Cardiovasc Dis. 2009;102:509-518.
40. Morales DL, Almond CS, Jaquiss RD, Rosenthal DN, Naftel DC, Massicotte MP, Humpl T, Turrentine MW, Tweddell JS, Cohen GA, Kroslowitz R, Devaney EJ, Canter CE, Fynn-Thompson F, Reinhartz O, Imamura M, Ghanayem NS, Buchholz H, Furness S, Mazor R, Gandhi SK, Fraser CD Jr. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011; 30:1-8.
41. Wheeldon DR, Jansen PG, Portner PM. The Novacor electrical implantable left ventricular assist system. Perfusion. 2000;15:355-361.
42. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assistance device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
43. Wieselthaler GM, O Driscoll G, Jansz P, Khaghani A, Strueber M; HVAD Clinical Investigators. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multiinstitutional trial. J Heart Lung Transplant. 2010;29:1218-1225.
44. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
45. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JB, Naka Y, Mancini D, Delgado RM, MacGillivray ET, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.
46. Goldstein DJ. Worldwide experience with the MicroMed DeBakey ventricular assist device as a bridge to transplantation. Circulation. 2003; 108(suppl 1):II-272-II-277.
47. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, McClellan D, Slepian MJ; CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859-867.
48. Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010. Circulation. 2010;122:173-183.
49. Freudenberger RS, Tawfik I, Shinnar M, Pendergast T. Panel-reactive screening and treatment practices following bridge to transplantation ventricular assist device placement. Transplant Proc. 2009;41: 1813-1815.
50. Robertson JO, Lober C, Smedira NG, Navia JL, Sopko N, Gonzalez-Stawinski GV. One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation. Eur J Cardiothorac Surg. 2008;34:295-300.
51. Alba AC, McDonald M, Rao V, Ross HJ, Delgado DH. The effect of ventricular assist devices on long-term post-transplant outcomes: a systematic review of observational studies. Eur J Heart Fail. 2011; 785-795.
52. Pal JD, Piacentino V, Cuevas AD, Depp T, Daneshmand MA, Hernandez AF, Felker GM, Lodge AJ, Rogers JG, Milano CA. Impact of left ventricular assist device bridging on posttransplant outcomes. Ann Thorac Surg. 2009;88:1457-1461.
53. Frazier OH, Rose EA, Oz MC, Dembitsky WP, McCarthy PM, Radovancevic B, Poirier VL, Dasse KA. Multicenter clinical evaluation of the heartmate: vented electric left ventricular assist system in patients awaiting heart transplantation. J Heart Lung Transplant. 2001;20: 201-202.
54. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
55. Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D; REMATCH Investigators. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation. 2004;110: 975-981.
56. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN 3rd; INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741-747.
57. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg. 2004;77:133-142.
58. Yamazaki K, Saito S, Nishinaka T, Kurosawa H, Nakatani T, Kobayashi J, Kitamura S, Matsumiya G, Yoshiki S, Nishimura T, Niinami H, Kyo S. 517: Japanese Clinical Trial Results of an Implantable Centrifugal Blood Pump "EVAHEART" [abstract]. J Heart Lung Transplant. 2008; 27(suppl 1):S246.
59. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL, Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce SW; for the HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125: 3191-3200.
60. Meyns B, Klotz S, Simon A, Droogne W, Rega F, Griffith B, Dowling R, Zucker MJ, Burkhoff D. Proof of concept: hemodynamic response to long-term partial ventricular support with the Synergy Pocket Micro-Pump. J Am Coll Cardiol. 2009;54:79-86.
61. Mandeep MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25:1024-1042.
62. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424-1433.
63. Teuteberg JJ, Lewis EF, Nohria A, Tsang SW, Fang JC, Givertz MM, Jarcho JA, Mudge GH, Baughman KL, Stevenson LW. Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail. 2006;12:47-53.
64. Mahon NG, Blackstone EH, Francis GS, Starling RC 3rd, Young JB, Lauer MS. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol. 2002;40:1106-1113.
65. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006;97: 1759-1764.
66. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW; REMATCH Investigators. Can the Seattle Heart Failure Model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant. 2009;28:231-236.
67. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S, Laskar S, Puskas J, Dunbar S, Vega D, Levy WC, Butler J. Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol. 2009;53:334-342.
68. Gorodeski EZ, Chu EC, Chow CH, Levy WC, Hsich E, Starling RC. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail. 2010;3:706-714.
69. Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF Jr, Gheorghiade M, O'Connor CM. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004;10: 460-466.
70. Fonarow GC Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-580.
71. Rector TS, Ringwala SN, Ringwala SN, Anand IS. Validation of a risk score for dying within 1 year of an admission for heart failure. J Card Fail. 2006;12:276-280.
72. Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R, Hochadel M, Marco J, Gitt A. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI. EuroIntervention. 2011;7:437-441.
73. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260-266.
74. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116:1482-1487.
75. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg. 2003;125:855-862.
76. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535-541.
77. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant. 2009;28:827-833.
78. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ; HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(suppl):S1-S39.
79. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1-10.
80. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. J Card Fail. 2010;16:855-858.
81. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505.
82. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese KA, Vargo RL, McCarthy PM, Rose EA, Levin HR. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995;92(suppl 1):II-169-II-173.
83. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, Cleeton T, Koenig SC, Edwards L, Kirklin JK. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009;28:44-50.
84. Norman JC, Cooley DA, Igo SR, Hibbs CW, Johnson MD, Bennett JG, Fuqua JM, Trono R, Edmonds CH. Prognostic índices for survival during postcardiotomy intra-aortic balloon pumping: methods of scoring and classification, with implications for left ventricular assist device utilization. J Thorac Cardiovasc Surg. 1977;74:709-720.
85. Oz MC, Slater JP, Edwards N, Dickstein ML, Beck JR, Spotnitz HM, Levin HR. Desaturated venous-to-arterial shunting reduces right-sided heart failure after cardiopulmonary bypass. J Heart Lung Transplant. 1995;14(pt 1):172-176.
86. McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ. Implantable left ventricular assist device: approaching an alternative for end-stage heart failure: Implantable LVAD Study Group. Circulation. 1994;90(pt 2):II-83-II-86.
87. Deng MC LM, El-Banayosy A, Gronda E, Jansen PG, Vigano M, Wieselthaler GM, Reichart B, Vitali E, Pavie A, Mesana T, Loisance DY, Wheeldon DR, Portner PM. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103: 231-237.
88. Hernandez AF, Grab JD, Gammie JS, O'Brien SM, Hammill BG, Rogers JG, Camacho MT, Dullum MK, Ferguson TB, Peterson ED. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation. 2007;116:606-612.
89. Magovern GJ, Golding LA, Oyer PE, Cabrol C. Circulatory support 1988: weaning and bridging. Ann Thorac Surg. 1989;47:102-107.
90. Slaughter MS, Tsui SS, El-Banayosy A, Sun BC, Kormos RL, Mueller DK, Massey HT, Icenogle TB, Farrar DJ, Hill JD; IVAD Study Group. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J Thorac Cardiovasc Surg. 2007;133: 1573-1580.
91. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, Oz MC, Naka Y. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1-6.
92. Kavarana M, Pessin-Minsley M, Urtecho J, Catanese K, Flannery M, Oz M, Naka Y. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73:745-750.
93. Morgan J, John R, Lee B, Oz M, Naka Y. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg. 2004;77:859-863.
94. Frazier O, Rose E, McCarthy P, Burton N, Tector A, Levin H, Kayne H, Poirier V, Dasse K. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327-336.
95. Ochiai Y, McCarthy P, Smedira N, Banbury M, Navia J, Feng J, Hsu A, Yeager M, Buda T, Hoercher K, Howard MW, Takagaki M, Doi K, Fukamachi K. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106(suppl 1):198-202.
96. Santambrogio L, Bianchi T, Fuardo M, Gazzoli F, Veronesi R, Braschi A, Maurelli M. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg. 2006;5:379-382.
97. Salzberg SP, Lachat ML, von Harbou K, Zund G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg. 2005;27: 222-225.
98. Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg. 2007;133:689-695.
99. Haddad H, Elabbassi W, Moustafa S, Davies R, Mesana T, Hendry P, Masters R, Mussivand T. Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. ASAIO J. 2005;51:456-460.
100. Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Eur J Cardiothorac Surg. 2009;35:1029-1034.
101. Nair PK, Kormos RL, Teuteberg JJ, Mathier MA, Bermudez CA, Toyoda Y, Dew MA, Simon MA. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant. 2010;29:201-208.
102. Torre-Amione G, Southard RE, Loebe MM, Youker KA, Bruckner B, Estep JD, Tierney M, Noon GP. Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. J Heart Lung Transplant. 2010;29:195-200.
103. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316-1324.
104. Fitzpatrick JR 3rd Frederick JR, Hsu VM, Kozin ED, O'Hara ML, Howell E, Dougherty D, McCormick RC, Laporte CA, Cohen JE, Southerland KW, Howard JL, Jessup ML, Morris RJ, Acker MA, Woo YJ. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27:1286-1292.
105. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score: a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163-2172.
106. Potapov E, Meyer D, Swaminathan M, Ramsay M, El Banayosy A, Diehl C, Veynovich B, Gregoric ID, Lukucka M, Gromann TW, Marczin N, Chittuluru K, Baldassarre JS, Zucker MJ, Hetzer R. Use of inhaled nitric oxide after left ventricular assist device placement: results of a prospective, randomized, double-blind, multicenter, placebocontrolled trial. Circulation. 2011;30:870-878.
107. Klotz S, Vahlhaus C, Riehl C, Reitz C, Sindermann J, Scheld H. Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters. J Heart Lung Transplant. 2010;29:45-52.
108. Schenk S, McCarthy PM, Blackstone EH, Feng J, Starling RC, Navia J, Zhou L, Hoercher KJ Smedira NG, Fukamachi K. Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg. 2006;131:447-454.
109. Faber C, McCarthy PM, Smedira NG, Young JB, Starling RC, Hoercher KJ. Implantable left ventricular assist device for patients with postinfarction ventricular septal defect. J Thorac Cardiovasc Surg. 2002;124: 400-401.
110. Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail. 2011;4:266-275.
111. Joyce DL, Crow SS, John R, St Louis JD, Braunlin EA, Pyles LA, Kofflin P, Joyce LD. Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J Heart Lung Transplant. 2010;29:1302-1305.
112. Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). J Thorac Cardiovasc Surg. 2004;127:264-266.
113. Savage EB, d'Amato TA, Magovern JA. Aortic valve patch closure: an alternative to replacement with HeartMate LVAS insertion. Eur J Cardiothorac Surg. 1999;16:359-361.
114. Rao V, Slater JP, Edwards NM, Naka Y, Oz MC. Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg. 2001;71:1448-1453.
115. Feldman CM, Silver MA, Sobieski MA, Slaughter MS. Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement. J Heart Lung Transplant. 2006;25: 1410-1412.
116. Krishan K, Pinney S, Anyanwu AC. Successful use of continuous flow ventricular assist device in a patient with mechanical mitral and aortic valve prosthesis without replacement or exclusion of valves. Interact Cardiovasc Thorac Surg. 2010;10:325-327.
117. Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis. 2002;6:947-967, viii-ix.
118. Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010;3:59-64.
119. Kaplon RJ, Gillinov AM, Smedira NG, Kottke-Marchant K, Wang IW, Goormastic M, McCarthy PM. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant. 1999;18: 346-350.
120. Farrar DJ, Hill JD. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices: Thoratec Ventricular Assist Device Principal Investigators. J Heart Lung Transplant. 1994;13:1125-1132.
121. Letsou GV, Myers TJ, Gregoric ID, Delgado R, Shah N, Robertson K, Radovancevic B, Frazier OH. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg. 2003;76:1167-1170.
122. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous-or pulsatile-flow assist devices. J Heart Lung Transplant. 2007;26:815-818.
123. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV; HeartMate II Clinical Investigators. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation. 2009;120:2352-2357.
124. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Grimm M, Wolner E, Wieselthaler GM. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg. 2009;87:1072-1078.
125. Topkara VK, Dang NC, Barili F, Cheema FH, Martens TP, George I, Bardakci H, Oz MC, Naka Y. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant. 2006;25:404-408.
126. Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant. 2009;28:352-359.
127. Demirozu ZT, Etheridge WB, Radovancevic R, Frazier OH. Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant. 2010;30:182-187.
128. Dalrymple LS, Johansen KL, Chertow GM, Cheng SC, Grimes B, Gold EB, Kaysen GA. Infection-related hospitalizations in older patients with ESRD. Am J Kidney Dis. 2010;56:522-530.
129. Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90:1270-1277.
130. Lazar RM, Shapiro PA, Jaski BE, Parides MK, Bourge RC, Watson JT, Damme L, Dembitsky W, Hosenpud JD, Gupta L, Tierney A, Kraus T, Naka Y. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004;109:2423-2427.
131. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-1213.
132. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, Garry D, Thomas W, Joyce L. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009; 137:208-215.
133. Musci M, Loforte A, Potapov E, Krabatsch T, Weng Y, Pasic M, Hetzer R. Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg. 2008;86:1236-1242.
134. Holdy K, Dembitsky W, Eaton LL, Chillcott S, Stahovich M, Rasmusson B, Pagani F. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant. 2005;24: 1690-1696.
135. Grady KL, White-Williams C, Naftel D, Costanzo MR, Pitts D, Rayburn B, VanBakel A, Jaski B, Bourge R, Kirklin J. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices: Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant. 1999;18:750-763.
136. Butler J, Howser R, Portner PM, Pierson RN 3rd. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg. 2005;79:66-73.
137. Coyle LA, Ising MS, Gallagher C, Bhat G, Kurien S, Sobieski MA, Slaughter MS. Destination therapy: one-year outcomes in patients with a body mass index greater than 30. Artif Organs. 2010;34:93-97.
138. Martin SI, Wellington L, Stevenson KB, Mangino JE, Sai-Sudhakar CB, Firstenberg MS, Blais D, Sun BC. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Interact Cardiovasc Thorac Surg. 2010;11:20-23.
139. Raymond AL, Kfoury AG, Bishop CJ, Davis ES, Goebel KM, Stoker S, Selzman CH, Clayson SE, Smith H, Cowley CG, Alharethi R, Budge D, Reid BB. Obesity and left ventricular assist device driveline exit site infection. ASAIO J. 2010;56:57-60.
140. Thompson K, Dhesi P, Nguyen D, Czer L, Moriguchi J, Schwarz E. Evaluation of the HeartMate IITM left ventricular assist device in obese heart failure patients: effects on weight loss. Ann Transplant. 2011;16: 63-67.
141. Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant. 2006;25:756-764.
142. Eshelman AK, Mason S, Nemeh H, Williams C. LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant. Heart Fail Rev. 2009;14: 21-28.
143. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, Ulisney K, Young JB. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27:1065-1072.